# Parnax Lab Ltd (PARNAXLAB)
> Exchange: NSE | Sector: Pharma | ISIN: INE383L01019

## Price
Current Price: ₹157.1
Day Change: +1.7%
52W High: ₹182
52W Low: ₹90.17
Market Cap: ₹186 Cr

## Valuation
P/E: 14.84
P/B: 2.07
EPS: ₹10.9
Book Value: ₹78.1
Dividend Yield: 0%

## Returns
1Y Return: 59.09%

## Profitability
ROE: 18.18%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: 0%
Profit Growth: 0%
EBITDA Margin: 0%
Operating Margin: 0%

## About
Parnax Lab Ltd is a Drug Manufacturers - Specialty & Generic company listed on BSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Parnax Lab Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Announcement: Closure of Trading Window
- BSE Filing: Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

## Access
Current tier: anonymous
More history: Register free to see 9 more years.

## Data Freshness
Quote Updated: 2026-05-18T09:45:20.317Z
Price History Updated: 2026-05-18T09:45:20.829Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T09:45:20.829Z
Quant Updated: 2026-05-18T09:45:20.829Z
Sentiment Updated: 2026-05-18T09:45:20.829Z
Financials Status: current
Financials Updated: 2026-05-18T12:30:01.148Z
Financials Last Attempt: 2026-05-18T12:30:01.148Z
Financials Provider Tried: database
Latest P&L Period: FY 2025
Latest Balance Sheet Period: FY 2025
Latest Cash Flow Period: FY 2025

## P&L (Mar 2015)
Revenue: ₹19.45 Cr
Operating Profit: ₹-0.12 Cr (OPM -0.62%)
Net Profit: ₹-1.21 Cr
Tax: ₹-1.46 Cr

## Annual P&L History
Mar 2015: Rev ₹19.45Cr | PAT ₹-1.21Cr | OPM -0.62%
Mar 2016: Rev ₹15.86Cr | PAT ₹-1.2Cr | OPM -2.08%
Mar 2017: Rev ₹7.12Cr | PAT ₹-1.01Cr | OPM -5.62%

## Balance Sheet (Mar 2015)
Total Assets: ₹36.8 Cr
Total Liabilities: ₹36.8 Cr
Borrowings: ₹16.56 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

---
Source: rupiya.io/stocks/parnaxlab
Disclaimer: For research and education only. Not investment advice.